P-Cure

P-Cure has commercialized the world’s first FDA-cleared gantry-less adaptive proton therapy system that enables cost-effective, compact installation of advanced proton radiation for cancer treatment. The solution allows both seated and supine patient positioning, integrates advanced imaging for precise targeting, reduces collateral radiation to healthy tissue, and significantly lowers capital costs compared to legacy systems. Clinical use includes all standard indications for proton therapy; specific clinical results are not detailed but the technology aims to improve dose distribution and reduce side effects.[1][2][6]

The company’s system has been installed in multiple locations globally.

No specific trial data or published outcomes are cited in available sources.

Pipeline breadth reflects a single core product platform with modular components rather than a portfolio of drugs/devices.